Literature DB >> 18003682

Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Vuyisile T Nkomo1.   

Abstract

Valvular heart diseases in Africa affect mainly children and young adults and are a result of rheumatic fever. Rheumatic fever is a preventable disease, but in Africa the combination of a lack of resources, lack of infrastructure, political, social and economic instability, poverty, overcrowding, malnutrition and lack of political will contributes to the persistence of a high burden of rheumatic fever, rheumatic valvular heart diseases and infective endocarditis. Combating and eradicating rheumatic fever and rheumatic heart diseases requires economic development and implementation of best practices of primary and secondary prevention measures. The barriers to achieving this goal in Africa are numerous, but not insurmountable.

Entities:  

Mesh:

Year:  2007        PMID: 18003682      PMCID: PMC2095773          DOI: 10.1136/hrt.2007.118810

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  152 in total

1.  [Incidence of cardiopathies, mainly rheumatic cardiopathies, in school children in the Ivory Coast].

Authors:  E Bertrand; M Coly; J Chauvet; A O Coulibaly; R Darracq; B Dienot; D Metras; R N Dori; M Odi Assamoi; K Ouattara; J Renambot
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Subvalvular left ventricular aneurysms. A report of 5 Ugandan cases.

Authors:  A A Poltera; A W Jones
Journal:  Br Heart J       Date:  1973-10

3.  The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project.

Authors:  T Strasser; N Dondog; A El Kholy; R Gharagozloo; V V Kalbian; O Ogunbi; S Padmavati; K Stuart; E Dowd; A Bekessy
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

4.  The group A streptococcal upper respiratory tract carrier state: an enigma.

Authors:  E L Kaplan
Journal:  J Pediatr       Date:  1980-09       Impact factor: 4.406

5.  Emergency heart valve replacement: an analysis of 170 patients.

Authors:  J W Louw; R H Kinsley; R A Dion; P R Colsen; R W Girdwood
Journal:  Ann Thorac Surg       Date:  1980-05       Impact factor: 4.330

6.  Aortic valve replacement in the elderly.

Authors:  P J Commerford; A Curcio; M Albanese; W Beck
Journal:  S Afr Med J       Date:  1981-06-27

7.  Childhood rheumatic heart disease in Nigeria.

Authors:  F Jaiyesimi; A U Antia
Journal:  Trop Geogr Med       Date:  1981-03

8.  Cardiac failure in pregnant Northern Nigerian women.

Authors:  C U Abengowe; C K Das; A K Siddique
Journal:  Int J Gynaecol Obstet       Date:  1980 Mar-Apr       Impact factor: 3.561

9.  Incidence of heart disease in pregnancy. A study done at Peninsula Maternity Services hospitals.

Authors:  R W Rush; M Verjans; F H Spracklen
Journal:  S Afr Med J       Date:  1979-05-12

10.  An epidemiological study of rheumatic fever and rheumatic heart disease in Lagos.

Authors:  O Ogunbi; H O Fadahunsi; I Ahmed; A Animashaun; S O Daniel; D U Onuoha; L Q Ogunbi
Journal:  J Epidemiol Community Health       Date:  1978-03       Impact factor: 3.710

View more
  33 in total

1.  Global trends in infective endocarditis epidemiology.

Authors:  Haur Sen Yew; David R Murdoch
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Infective Endocarditis in French West Indies: A 13-Year Observational Study.

Authors:  Elisabeth Fernandes; Claude Olive; Jocelyn Inamo; François Roques; André Cabié; Patrick Hochedez
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

3.  Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France.

Authors:  George Watt; Adele Lacroix; Orathai Pachirat; Henry C Baggett; Didier Raoult; Pierre-Edouard Fournier; Pierre Tattevin
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

4.  Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice.

Authors:  Grace Casaclang-Verzosa; Maurice Enriquez-Sarano; Hector R Villaraga; Jordan D Miller
Journal:  J Vis Exp       Date:  2017-02-14       Impact factor: 1.355

5.  HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease.

Authors:  Nashwa El-Hagrassy; Farha El-Chennawi; Maysaa El-Sayed Zaki; Hossam Fawzy; Adel Zaki; Nabeil Joseph
Journal:  Pediatr Cardiol       Date:  2010-02-10       Impact factor: 1.655

6.  Pioneer human open heart surgery using cardiopulmonary by pass in Uganda.

Authors:  C Akomea-Agyin; M Galukande; T Mwambu; S Ttendo; I Clarke
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

7.  Changing profile of infective endocarditis: a clinicopathologic study of 220 patients in a single medical center from 1998 through 2009.

Authors:  Li Li; Hongyue Wang; Linlin Wang; Jielin Pu; Hong Zhao
Journal:  Tex Heart Inst J       Date:  2014-10-01

8.  Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study.

Authors:  Ganesan Karthikeyan; Liesl Zühlke; Mark Engel; Sumathy Rangarajan; Salim Yusuf; Koon Teo; Bongani M Mayosi
Journal:  Am Heart J       Date:  2012-03-12       Impact factor: 4.749

9.  Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals.

Authors:  P V Damasco; J N Ramos; J C D Correal; M V Potsch; V V Vieira; T C F Camello; M P Pereira; V D Marques; K R N Santos; E A Marques; M B Castier; R Hirata; A L Mattos-Guaraldi; C Q Fortes
Journal:  Infection       Date:  2014-06-17       Impact factor: 3.553

10.  Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance.

Authors:  Emma K Nickerson; Maliwan Hongsuwan; Direk Limmathurotsakul; Vanaporn Wuthiekanun; Krupal R Shah; Pramot Srisomang; Weera Mahavanakul; Therapon Wacharaprechasgul; Vance G Fowler; T Eoin West; Nitaya Teerawatanasuk; Harald Becher; Nicholas J White; Wirongrong Chierakul; Nicholas P Day; Sharon J Peacock
Journal:  PLoS One       Date:  2009-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.